Exploring the Interplay Between Glycated Albumin, AGEs, and Inflammation in Old Patients with CKD
Simone Vettoretti1,2, Lara Caldiroli3, Paolo Molinari3
1Unit of Nephrology and Dialysis Fondazione IRCCS San Gerardo di Monza, 20900 Monza, Italy.
Metabolites
|August 27, 2025
Summary
In elderly patients with severe chronic kidney disease (CKD), glycated albumin (GA) reflects glycemic control better than glycation stress. This finding is crucial for managing cardiovascular risk in CKD patients.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) elevates cardiovascular risk via oxidative stress and advanced glycation end products (AGEs).
- Glycated albumin (GA) is linked to cardiovascular risk in CKD, but its connection to AGEs and inflammation is not fully understood.
- Investigating these relationships is vital for understanding CKD pathophysiology and patient outcomes.
Purpose of the Study:
- To examine the associations between glycated albumin (GA), advanced glycation end products (AGEs), receptor for AGEs (RAGE) isoforms, and systemic inflammation in elderly patients with severe CKD.
- To differentiate the roles of GA and AGEs in the context of glycemic control and CKD severity.
- To identify independent predictors of GA in this patient population.
Main Methods:
- Cross-sectional analysis of 122 elderly patients (≥65 years) with CKD stages G3a-G5, including diabetic and non-diabetic subgroups.
- Exclusion of patients with confounding comorbidities to ensure study focus.
- Measurement of GA, AGEs, RAGE isoforms, and inflammatory cytokines (CRP, IL-6, TNFα, MCP-1) using standardized assays, followed by statistical analyses including correlation and multivariate regression.
Main Results:
- Diabetic patients exhibited significantly higher GA levels compared to non-diabetics (22.0 ± 7.1% vs. 17.5 ± 5.4%, p=0.0001).
- No significant differences were observed in AGEs or key inflammatory markers between diabetic and non-diabetic groups.
- Glycated albumin (GA) showed an inverse correlation with eGFR and a positive correlation with HbA1c, but was not significantly correlated with AGEs, RAGE, or inflammatory markers. HbA1c was the sole independent predictor of GA.
Conclusions:
- In elderly individuals with severe CKD, glycated albumin (GA) serves as a more pertinent indicator of glycemic control than overall glycation stress.
- Glycation stress, influenced by factors like kidney function and inflammation, does not directly correlate with GA in this cohort.
- These findings highlight the importance of monitoring GA for assessing glycemic control in elderly CKD patients.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
78
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
78
01:25Chronic Kidney Disease I: Introduction
67
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
67
01:24Chronic Kidney Disease II: Clinical Manifestations
87
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
87
01:24Nephrotic Syndrome I : Introduction
27
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
27
01:18Chronic Kidney Disease IV: Nursing Management
55
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
55
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57